Coldstream Capital Management Inc Ionis Pharmaceuticals Inc Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,345 shares of IONS stock, worth $78,909. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,345Holding current value
$78,909% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
397Shares Held
141MCall Options Held
707KPut Options Held
711K-
Vanguard Group Inc Valley Forge, PA16.4MShares$551 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$544 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$416 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$347 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$283 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.78B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...